Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo

Lipids

Volumn 34, Issue 12, 1999, Pages 1273-1280

  Bassett, Casey N ^a   Neely, M Diana ^a   Sidell, Kathrin R ^a   Markesbery, William R ^c   Swift, Larry L ^a   Montine, Thomas J ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN;

ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; HUMAN; HUMAN TISSUE; LIPID ANALYSIS; LIPID PEROXIDATION; NERVE DEGENERATION; NEUROTOXICITY; PATHOGENESIS; PROTEIN CEREBROSPINAL FLUID LEVEL;

EID: 0033374599     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11745-999-0478-1     Document Type: Article

References (49)

1. National Institutes of Health (1998) Alzheimer's Disease. Unraveling the Mystery, Washington, DC.
2. St. George-Hyslop, G. (1998) Genetics of Alzheimer's Disease, in Neuropathology of Dementing Disorders (Markesbery, W.R., ed.), pp. 106-120, Arnold, London.
3. Schofield, P., and Mayeux, R. (1998) Alzheimer's Disease: Clinical Features, Diagnosis, and Epidemiology, in Neuropathology of Dementing Disorders (Markesbery, W.R., ed.), pp. 89-105, Arnold, London.
4. Price, D.L., Thinakaran, G., Borchelt, D.R., Martin, L.J., Sisodia, S.S., and Troncoso, J.C. (1998) Neuropathology of Alzheimer's Disease and Animal Models, in Neuropathology of Dementing Disorders (Markesbery, W.R., ed.), pp. 121-141, Arnold, London.
5. Markesbery, W.R., and Carney, J.M. (1999) Oxidative Alterations in Alzheimer's Disease, Brain Pathol. 9, 133-146.
6. Halliwell, B. (1992) Reactive Oxygen Species and the Central Nervous System, J. Neurochem. 59, 1609-1623.
7. 2-isoprostane Concentration in Probable Alzheimer's Disease, Neurology 52, 562-565.
8. Keller, J.N., and Mattson, M.P. (1998) Roles of Lipid Peroxidation in Modulation of Cellular Signaling Pathways, Cell Dysfunction, and Death in the Nervous System, Rev. Neurosci. 9, 105-116.
9. Mahley, R.W. (1988) Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology, Science 240, 622-630.
10. Borghini, I., Barja, F., Pometta, D., and James, R. (1995) Characterization of Subpopulations of Lipoprotein Particles Isolated from Human Cerebrospinal Fluid, Biochim. Biophys. Acta 1225, 192-200.
11. LaDu, M.J., Gilligan, S.M., Lukens, J.R., Cabana, V.G., Reardon, C.A., VanEldik, L.J., and Holtzman, D.M. (1998) Nascent Astrocyte Particles Differ from Lipoproteins in CSF. J. Neurochem. 70, 2070-2081.
12. Pitas, R.E., Boyles, J.K., Lee, S.H., Hui, D., and Weisgraber, K.H. (1987) Lipoproteins and Their Receptors in the Central Nervous System. J. Biol. Chem. 262, 14352-14360.
13. Roheim, P.S., Carey, M., Forte, T., and Vega, G.L. (1979) Apolipoproteins in Human Cerebrospinal Fluid, Proc. Natl. Acad. Sci. USA 76, 4646-4649.
14. Pitas, R., Boyles, J., Lee, S., Foss, D., and Mahley, R. (1987) Astrocytes Synthesize Apolipoprotein E and Metabolize Apoplipoprotein E-Containing Lipoproteins, Biochim. Biophys. Acta 917, 148-161.
15. Mahley, R.W., Innerarity, T.L., Rall, S.C., and Weisgraber, K.H. (1984) Plasma Lipoproteins: Apolipoprotein Structure and Function, J. Lipid Res. 25, 1277-1294.
16. Montine, T.J., Montine, K.S., and Swift, L.L. (1997) Central Nervous System Lipoproteins in Alzheimer's Disease, Am. J. Pathol. 151, 1571-1575.
17. Montine, K.S., Bassett, C.N., Ou, J.J., Markesbery, W.R., Swift, L.L., and Montine, T.J. (1998) Apolipoprotein E Allelic Influence on Human Ventricular Fluid Apolipoproteins, J. Lipid Res. 38, 2443-2451.
18. Ronald and Nancy Reagan Institute of lhe Alzheimer's Association and National Institute on Aging Working Group on Biological Markers of Alzheimer's Disease (1998) Consensus Report on the Working Group on 'Molecular and Biochemical Markers of Alzheimer's Disease,' Neurobiol. Aging 19, 109-116.
19. Braak, H., and Braak. E. (1991) Neuropathological Staging of Alzheimer-Related Changes, Acta Neuropathol. 82, 239-259.
20. Saunders, A.M., Strittmatter, W.J., Schmechel, D., St. George-Hyslop, P.H., Pericak-Vance, M.A., Joo, S.H., Rosi, B.L., Gusella, J.F., Crapper, M.D., Alberts, M.J., Hulette, C., Crain, B., Goldgaber, D., and Roses, A.D. (1993) Association of Apolipoprotein E Allele Epsilon 4 with Late-Onset Familial and Sporadic Alzheimer's Disease, Neurology 43, 1467-1472.
21. Esterbauer, H., and Ramos, P. (1995) Chemistry and Pathophysiology of Oxidation of LDL, Rev. Physiol. Biochem. Pharmacol. 127, 31-64.
22. Puhl, H., Waeg, G., and Esterbauer, H. (1994) Methods to Determine Oxidation of Low-Density Lipoproteins, Methods Enzymol. 233, 425-441.
23. Neely, M.D., Sidell, K.R., Graham, D.G., and Montine, T.J. (1998) The Lipid Peroxidation Product 4-Hydroxynonenal Inhibits Neurite Outgrowth and Disrupts Neuronal Microtubules, J. Neurochem. 72, 2323-2333.
24. Pitas, R.E., Innerarity, T.L., Weinstein, J.N., and Mahley, R.W. (1981) Acetoacetylated Lipoproteins Used to Distinguish Fibroblasts from Macrophages in Vitro by Fluorescence Microscopy, Atherosclerosis I, 177-185.
25. Morrison, W., and Smith, L. (1964) Preparation of Fatty Acid Methyl Esters and Dimethylacetals from Lipids with Boron Fluoride-Methanol, J. Lipid Res. 5, 600-608.
26. Esterbauer, H., Dieber-Rothneder, M., Waeg, G., Striegl, G., and Jurgens, G. (1990) Biochemical, Structural, and Functional Properties of Oxidized Low-Density Lipoprotein, Chem. Res. Toxicol. 3, 77-92.
27. Esterbauer, H., Schaur, R.J., and Zollner, H. (1991) Chemistry and Biochemistry of 4-Hydroxynonenal, Malondialdehyde and Related Aldehydes, Free Radical Biol. Med 11, 81-128.
28. Mahley, R., Nathan, B., Bellosta, S., and Pitas, R. (1995) Apolipoprotein E: Impact of Cytoskeletal Stability in Neurons and the Relationship to Alzheimer's Disease, Current Opin. Lipid. 6, 86-91.
29. Gutteridge, J.M.C., and Halliwell, B. (1990) The Measurement and Mechanism of Lipid Peroxidation in Biological Systems, Trends Biochem. Sci. 15, 129-135.
30. Gonzalez-Scarano, F., and Baltuch, G. (1999) Microglia as Mediators of Inflammatory and Degenerative Diseases, Annu. Rev. Neurosci. 22, 219-240.
31. Kjeldsberg, C.R., and Krieg, A.F. (1984) Cerebrospinal Fluid and Other Body Fluids, in Clinical Diagnosis and Management by Laboratory Methods (Henry, J.B., ed.), pp. 459-492, W.B. Saunders Co., Philadelphia.
32. Noguchi, N., Gotoh, N., and Niki, E. (1993) Dynamics of the Oxidation of Low Density Lipoprotein Induced by Free Radicals, Biochim. Biophys. Acta 1168, 348-357.
33. Gotz, M.E., Freyberger, A., Hauer, E., Burger, R., Sofic, E., Gsell, W., Heckers, S., Jellinger, K., Hebenstreit, G., Frolich, L., Beckmann, H., and Riederer, P. (1992) Susceptibility of Brains from Patients with Alzheimer's Disease to Oxygen-Stimulated Lipid Peroxidation and Differential Scanning Calorimetry, Dementia 3, 213-222.
34. McIntosh, L.J., Trush, M.A., and Troncoso, J.C. (1997) Increased Susceptibility of Alzheimer's Disease Temporal Cortex to Oxygen Free Radical-Mediated Processes, Free Radicals Biol. Med. 23, 183-190.
35. Subbarao, K.V., Richardson, J.S., and Ang, L.C. (1990) Autopsy Samples of Alzheimer's Cortex Show Increased Peroxidation in Vitro, J. Neurochem. 55, 342-345.
36. Sano, M., Ernesto, C., Thomas, R.G., Klauber, M.R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C.W., Pfeiffer, E., Schneider, L.S., and Thai, L.J. (1997) A Controlled Trial of Selegiline, α-Tocopherol, or Both as a Treatment for Alzheimer's Disease, New Engl. J. Med. 336, 1216-1222.
37. Miyata, M., and Smith, J.D. (1996) Apolipoprotein E Allele-Specific Antioxidant Activity and Effects on Cytotoxicity by Oxidative Insults and β-Amyloid Peptides, Nature Genetics 14, 55-61.
38. Steinbrecher, U.P. (1987) Oxidation of Human Low Density Lipoprotein Results in Derivatization of Lysine Residues of Apolipoprotein B by Lipid Peroxide Decomposition Products, J. Biol. Chem. 262, 3603-3608.
39. Hoff, H., and O'Neil, J. (1993) Structural and Functional Changes in LDL After Modification with both 4-Hydroxynonenal and Malondialdehyde, J. Lipid Res. 34, 1209-1217.
40. Regnstrom, J., Nilsson, J., Tornvall, P., Landou, C., and Hamsten, A. (1992) Susceptibility to Low Density Lipoprotein Oxidation and Coronary Atherosclerosis in Man, Lancet 339, 1183-1186.
41. Stalenhoef, A.F.H., Defesche, J.C., Kleinveld, H.A., Demacker, P.N.M., and Kastelein, J.J.P. (1994) Decreased Resistance Against in Vitro Oxidation of LDL from Patients with Familial Defective Apolipoprotein B-100, Arterioscler. Thromb. 14, 489-493.
42. Lavy, A., Brook, G.J., Danker, G., Amotz, A.M., and Aviram, M. (1991) Enhanced in Vitro Oxidation of Plasma Lipoproteins Derived from Hypercholesterolemic Patients, Metabolism 40, 794-799.
43. Cominachini, L., Garbin, U., Pastorino, A.M., Davoli, A., Campagnola, M., De Santis, A., Pasini, C., Faccini, G.B., Trevisan, M.T., Bertozzo, L., Pasini, F., and Lo Cascio, V. (1993) Predisposition to LDL Oxidation in Patients With and Without Angiographically Established Coronary Artery Disease, Atherosclerosis 99, 63-70.
44. Chiu, H.C., Jeng, J.R., and Shieh, S.M. (1994) Increased Oxidizability of Plasma Low Density Lipoprotein from Patients With Coronary Artery Disease, Biochim. Biophys. Acta 1225, 200-208.
45. Kontush, A., Spranger, T., Reich, A., Djahansouzi, S., Karten, B., Braesen, J.H., Finckh, B., Kohlschutter, A., and Beisiegel, U. (1997) Whole Plasma Oxidation Assay as a Measure of Lipoprotein Oxidizability, BioFactors 6, 99-109.
46. Sugawa, M., Ikeda, S., Kushima, Y., Takashima, Y., and Cynshi, O. (1997) Oxidized Low Density Lipoprotein Causes CNS Neuron Cell Death, Brain Res. 761, 165-172.
47. Keller, J.N., Hanni, K.B., and Markesbery, W.R. (1999) Oxidized Low-Density Lipoprotein Induces Neuronal Death, J. Neurochem. 72, 2601-2609.
48. Kivatinitz, S.C., Pelsman, M.A., Alonso, A.C., Bagatolli, L., and Quiroga, S. (1997) High Density Lipoprotein Aggregated by Oxidation Induces Degeneration of Neuronal Cells, J. Neurochem. 69, 2102-2114.
49. Draczynska-Lusiak, B., Doung, A., and Sun, A.Y. (1998) Oxidized Lipoproteins May Play a Role in Neuronal Cell Death in Alzheimer's Disease, Mol. Cell. Neuropath. 33, 139-148.